To establish a methodological framework for deriving occupational exposure limits for formaldehyde-releasing agents based on their carcinogenic potential and exposure characteristics.
Approach:
Assessment of Carcinogenicity: The framework evaluates the carcinogenicity of formaldehyde releasers by assessing substance-specific inhalation data, hydrolysis rates, formaldehyde release rates, and other relevant factors.
Case Studies: Four examples of formaldehyde releasers are analyzed to illustrate the derivation of MAK values and carcinogen classifications.
Key Findings:
Formaldehyde is classified as a human carcinogen (Category 1) by the International Agency for Research on Cancer (IARC) and as a Category 1B carcinogen by the European Chemicals Agency (ECHA).
Formaldehyde releasers are assumed to have similar effects as formaldehyde itself.
The MAK Commission derived specific MAK values for formaldehyde releasers based on inhalation studies and other relevant data.
Interpretation:
The classification and MAK value derivation for formaldehyde releasers depend on their specific characteristics and the rate of formaldehyde release in the respiratory tract.
Limitations:
The carcinogenicity of formaldehyde releasers may not be fully understood due to limited substance-specific inhalation data.
The framework relies on assumptions regarding the behavior of formaldehyde and its releasers in biological systems.
Conclusion:
The methodological framework provides a structured approach to assess the occupational exposure limits for formaldehyde-releasing agents, ensuring that potential risks are adequately addressed.
by Sandra Michaelsen, Britta Laube, Rüdiger Bartsch, Stephan Baumgärtel, Dietmar Breuer, Rolf Grebenstein, Edgar Leibold, Ruth Lohmann, Hans Merk, Carsten Schleh, Manigé Fartasch, Michael Bader, Hans Drexler, Brunhilde Blömeke, Andrea Hartwig
Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.
Integrated proteomic and metabolomic analyses identified redox-metabolic signatures associated with chronic posttraumatic stress disorder and accelerated biological aging across multiple organ systems.
